Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS. Mediterr J Hematol Infect Dis 2025, 17 (1), e2025026. https://doi.org/10.4084/MJHID.2025.026.